Barclays’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Buy |
348,109
+192,900
| +124% | +$1.25M | ﹤0.01% | 2145 |
|
|
2025
Q1 | $1.23M | Buy |
155,209
+13,757
| +10% | +$109K | ﹤0.01% | 2330 |
|
|
2024
Q4 | $1.79M | Buy |
141,452
+6,079
| +4% | +$77K | ﹤0.01% | 2270 |
|
|
2024
Q3 | $1.89M | Buy |
135,373
+79,779
| +144% | +$1.11M | ﹤0.01% | 2220 |
|
|
2024
Q2 | $765K | Sell |
55,594
-11,872
| -18% | -$163K | ﹤0.01% | 2270 |
|
|
2024
Q1 | $1.11M | Sell |
67,466
-118,373
| -64% | -$1.95M | ﹤0.01% | 2329 |
|
|
2023
Q4 | $2.71M | Buy |
185,839
+53,957
| +41% | +$788K | ﹤0.01% | 1946 |
|
|
2023
Q3 | $1.62M | Sell |
131,882
-12,521
| -9% | -$154K | ﹤0.01% | 1784 |
|
|
2023
Q2 | $1.72M | Buy |
144,403
+70,834
| +96% | +$846K | ﹤0.01% | 1826 |
|
|
2023
Q1 | $984K | Sell |
73,569
-35,983
| -33% | -$481K | ﹤0.01% | 2147 |
|
|
2022
Q4 | $2.36M | Buy |
109,552
+19,123
| +21% | +$412K | ﹤0.01% | 1545 |
|
|
2022
Q3 | $1.81M | Buy |
90,429
+89,257
| +7,616% | +$1.79M | ﹤0.01% | 1728 |
|
|
2022
Q2 | $21K | Sell |
1,172
-4,315
| -79% | -$77.3K | ﹤0.01% | 4066 |
|
|
2022
Q1 | $55K | Buy |
+5,487
| New | +$55K | ﹤0.01% | 3965 |
|